Wyeth and Ablynx Enter into Collaboration and Licence Agreement
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 78 (Table of Contents)
Published: 6 Dec-2006
DOI: 10.3833/pdr.v2006.i78.414 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Ablynx entered into research collaboration and license agreement with Wyeth Pharmaceuticals to discover, develop and commercialize nanobodies targeting TNF-alpha and its receptors in multiple therapeutic areas...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018